U.S. Markets closed

Cellular Biomedicine: 1Q Earnings Snapshot

NEW YORK (AP) _ Cellular Biomedicine Group Inc. (CBMG) on Wednesday reported a loss of $11.5 million in its first quarter.

The New York-based company said it had a loss of 60 cents per share. Losses, adjusted for asset impairment costs, were 59 cents per share.

Cellular Biomedicine shares have declined 14% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $14.02, a drop of 17% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CBMG at https://www.zacks.com/ap/CBMG